You are now leaving GSK’s website

You are now leaving a GSK Website. By clicking this link, you will be taken to a website that is not owned or controlled by GSK, and GSK is not responsible for the content provided on that site.

Continue

Go back

Video Centre

Shingrix Scientific Rationale

Shingrix with Dr. Das

Pharmacy Patient Conversation Starter

Importance of Adult Immunisation

Role of Pharmacist - Adult Immunisation

Effective Communication - Adult Immunisation

Adverse events should be reported directly to the Health Products Regulatory Authority (HPRA) on their website: www.hpra.ie. Adverse events should also be reported to GlaxoSmithKline on 1800 244 255.

SHINGRIX is owned by or licensed to the GSK group of companies.
©2023 GSK group of companies or its licensor.
GlaxoSmithKline Biologicals S.A. Rixensart, Belgium.

PM-IE-SGX-WCNT-240004
Date of preparation: May 2024